| Deciphering the language of antibodies using self-supervised learning J Leem, LS Mitchell, JHR Farmery, J Barton, JD Galson Patterns 3 (7), 2022 | 134 | 2022 |
| Benchmarking solutions to the T-cell receptor epitope prediction problem: IMMREP22 workshop report P Meysman, J Barton, B Bravi, L Cohen-Lavi, V Karnaukhov, E Lilleskov, ... ImmunoInformatics 9, 100024, 2023 | 75 | 2023 |
| Mechanistic diversity in MHC class I antigen recognition CRR Barbosa, J Barton, AJ Shepherd, M Mishto Biochemical Journal 478 (24), 4187-4202, 2021 | 20 | 2021 |
| What do we (Not) know about research software engineering? AL Lamprecht, C Martinez-Ortiz, M Barker, SL Bartholomew, J Barton, ... Journal of Open Research Software 10 (1), 2022 | 15 | 2022 |
| Enhancing Antibody Language Models with Structural Information J Barton, JD Galson, J Leem Machine Learning for Structural Biology Workshop, NeurIPS, 2023 | 11 | 2023 |
| Lessons learned from the IMMREP23 TCR-epitope prediction challenge M Nielsen, A Eugster, MF Jensen, M Goel, A Tiffeau-Mayer, A Pelissier, ... ImmunoInformatics 16, 100045, 2024 | 8 | 2024 |
| Benchmarking solutions to the T-cell receptor epitope prediction problem: IMMREP22 workshop report. ImmunoInformatics 2023; 9: 100024 P Meysman, J Barton, B Bravi, L Cohen-Lavi, V Karnaukhov, E Lilleskov J. IMMUNO 7, 2023 | 8 | 2023 |
| Deciphering the language of antibodies using self-supervised learning. Patterns 3, 100513 J Leem, LS Mitchell, JHR Farmery, J Barton, JD Galson | 7 | 2022 |
| Benchmarking solutions to the T-cell receptor epitope prediction problem: IMMREP22 workshop report. ImmunoInformatics 9, 100024 P Meysman, J Barton, B Bravi, L Cohen-Lavi, V Karnaukhov, E Lilleskov, ... | 5 | 2023 |
| Building representation learning models for antibody comprehension J Barton, A Gaspariunas, JD Galson, J Leem Cold Spring Harbor Perspectives in Biology 16 (3), a041462, 2024 | 3 | 2024 |
| A generative foundation model for antibody sequence understanding J Barton, A Gaspariunas, DA Yadin, J Dias, FL Nice, DH Minns, ... bioRxiv, 2024.05. 22.594943, 2024 | 2 | 2024 |
| An in silico drug repurposing pipeline to identify drugs with the potential to inhibit SARS-CoV-2 replication M MacMahon, W Hwang, S Yim, E MacMahon, A Abraham, J Barton, ... Informatics in Medicine Unlocked 43, 101387, 2023 | 1 | 2023 |
| Identification and validation of Triamcinolone and Gallopamil as treatments for early COVID-19 via an in silico repurposing pipeline M MacMahon, W Hwang, S Yim, E MacMahon, A Abraham, J Barton, ... | 1 | 2021 |
| Anti-unc5c antibodies I Pediaditakis, M Sidor, J McCarthy, L Sandrine, G Lewis, LS Mitchell, ... US Patent App. 18/408,509, 2024 | | 2024 |
| Determining a novel feature-space for SARS-CoV-2 sequence data F Ballesio, AH Bangash, D Barradas Bautista, J Barton, A Guarracino, ... Center for Open Science, 2020 | | 2020 |
Jacob GalsonAlchemab Therapeutics Ltd & University of ZurichVerified email at alchemab.com
